microRNA information: hsa-miR-185-3p

SectionIDlink
Mature name: hsa-miR-185-3pmiRbase
Accession: MIMAT0004611miRbase
Precursor name: hsa-mir-185 miRbase
Precursor accession: MI0000482miRbase
Symbol: MIR185HGNC
RefSeq ID: NR_029706GenBank
Sequence: AGGGGCUGGCUUUCCUCUGGUC


Reported expression in cancers: hsa-miR-185-3p

miRNAcancerregulationreportingPUBMEDmethod
hsa-miR-185-3p

breast cancerdownregulation"In this study we found that miR-185 was strongly d ......"25319390
hsa-miR-185-3p

breast cancerdownregulation"miR-185 has been demonstrated to be involved in th ......"25371748qPCR
hsa-miR-185-3p

colorectal cancerderegulation"miR 185 and miR 133b deregulation is associated wi ......"21573504qPCR
hsa-miR-185-3p

endometrial cancerderegulation"In endometrial cancer cells expression levels of m ......"26535032
hsa-miR-185-3p

esophageal cancerdownregulation"To explore the role and mechanism of microRNA185 m ......"24025511qPCR
hsa-miR-185-3p

gastric cancerderegulation"The results from the miRNA microarray analysis wer ......"21475928qPCR; Microarray
hsa-miR-185-3p

gastric cancerdownregulation"miR 185 is an independent prognosis factor and sup ......"24352663
hsa-miR-185-3p

gastric cancerupregulation"A total of 33 miRNAs were identified through the i ......"26059512Reverse transcription PCR; qPCR
hsa-miR-185-3p

liver cancerupregulation"Metastasis related miR 185 is a potential prognost ......"23648054Microarray
hsa-miR-185-3p

lung squamous cell cancerdownregulation"Increasing evidence has shown that microRNAs play ......"26617940
hsa-miR-185-3p

prostate cancerdownregulation"In this study miR-185 was found to be down-regulat ......"23417242
hsa-miR-185-3p

sarcomaderegulation"Hypoxic conditions were verified and miRNA express ......"24927770Microarray


Reported cancer pathway affected by hsa-miR-185-3p

miRNAcancerpathwayreportingPUBMEDfunctional study
hsa-miR-185-3p

breast cancerApoptosis pathway"MicroRNA 185 inhibits proliferation by targeting c ......"25371748Flow cytometry; MTT assay; Western blot; Luciferase
hsa-miR-185-3p

gastric cancerApoptosis pathway"MicroRNA 185 regulates chemotherapeutic sensitivit ......"24763054
hsa-miR-185-3p

gastric cancercell cycle pathway; Apoptosis pathway"TRIM29 functions as an oncogene in gastric cancer ......"26191199RNAi; Colony formation; Luciferase
hsa-miR-185-3p

kidney renal cell cancerApoptosis pathway"MicroRNA 185 inhibits cell proliferation and induc ......"25700976Colony formation; Cell Proliferation Assay; Luciferase
hsa-miR-185-3p

liver cancerEpithelial mesenchymal transition pathway"MicroRNA 185 inhibits cell proliferation and epith ......"27212161Wound Healing Assay; Western blot; Luciferase
hsa-miR-185-3p

lung squamous cell cancercell cycle pathway"MiR 107 and MiR 185 can induce cell cycle arrest i ......"19688090
hsa-miR-185-3p

ovarian cancerApoptosis pathway"MiR 152 and miR 185 co contribute to ovarian cance ......"23318422
hsa-miR-185-3p

prostate cancercell cycle pathway"MicroRNA 185 suppresses proliferation invasion mig ......"23417242Luciferase
hsa-miR-185-3p

prostate cancerApoptosis pathway"MicroRNA 185 and 342 inhibit tumorigenicity and in ......"23951060


Reported cancer prognosis affected by hsa-miR-185-3p

miRNAcancerprognosisreportingPUBMEDfunctional study
hsa-miR-185-3p

breast cancerstaging; metastasis; poor survival"miR 185 suppresses tumor proliferation by directly ......"25319390
hsa-miR-185-3p

breast cancermetastasis"RKIP suppresses the proliferation and metastasis o ......"27651238
hsa-miR-185-3p

colon cancermetastasis"MicroRNA 185 suppresses growth and invasion of col ......"25216407Western blot; MTT assay; Transwell assay
hsa-miR-185-3p

colon cancerstaging"We assessed by qRT-PCR expression of 754 microRNAs ......"27485175
hsa-miR-185-3p

colorectal cancermetastasis; poor survival"miR 185 and miR 133b deregulation is associated wi ......"21573504
hsa-miR-185-3p

colorectal cancermetastasis; worse prognosis"STIM1 a direct target of microRNA 185 promotes tum ......"25531324
hsa-miR-185-3p

endometrial cancermetastasis; tumorigenesis"In endometrial cancer cells expression levels of m ......"26535032
hsa-miR-185-3p

esophageal cancercell migration; metastasis"Plasma miR 185 is decreased in patients with esoph ......"26316588Luciferase
hsa-miR-185-3p

gastric cancermetastasis; worse prognosis; staging; progression; poor survival"miR 185 is an independent prognosis factor and sup ......"24352663
hsa-miR-185-3p

gastric cancerstaging"A total of 33 miRNAs were identified through the i ......"26059512
hsa-miR-185-3p

kidney renal cell cancerstaging; tumor size"MicroRNA 185 inhibits cell proliferation and induc ......"25700976Colony formation; Cell Proliferation Assay; Luciferase
hsa-miR-185-3p

liver cancerstaging; metastasis; recurrence; differentiation; tumor size; poor survival"Metastasis related miR 185 is a potential prognost ......"23648054
hsa-miR-185-3p

liver cancermetastasis; progression"MicroRNA 185 inhibits cell proliferation and epith ......"27212161Wound Healing Assay; Western blot; Luciferase
hsa-miR-185-3p

lung cancermalignant trasformation"Diagnostic Value of Circulating Extracellular miR ......"24851110
hsa-miR-185-3p

lung squamous cell cancerprogression; motility"MiR 185 acts as a tumor suppressor by targeting AK ......"26617940
hsa-miR-185-3p

ovarian cancerdrug resistance"MiR 152 and miR 185 co contribute to ovarian cance ......"23318422
hsa-miR-185-3p

prostate cancerdrug resistance"MiR 185 attenuates androgen receptor function in p ......"26940039Luciferase; Western blot
hsa-miR-185-3p

sarcomadrug resistance"Hypoxic conditions were verified and miRNA express ......"24927770Luciferase


Reported gene related to hsa-miR-185-3p

miRNAcancergenereportingPUBMED
hsa-miR-185-3p

prostate cancerAR"MicroRNA 185 downregulates androgen receptor expre ......"25673182
hsa-miR-185-3p

prostate cancerAR"MMTV-Fluc reporter assays revealed that miR-185 ca ......"26940039
hsa-miR-185-3p

prostate cancerAR"MicroRNA 185 suppresses proliferation invasion mig ......"23417242
hsa-miR-185-3p

esophageal cancerCDH1"After transfection of miR-185 inhibitor into KYSE3 ......"24025511
hsa-miR-185-3p

liver cancerCDH1"We also found that ectopic expression of miR-185 r ......"27212161
hsa-miR-185-3p

liver cancerDNMT1"miR-185 overexpression inhibited DNMT1 3' untransl ......"24911372
hsa-miR-185-3p

ovarian cancerDNMT1"MiR 152 and miR 185 co contribute to ovarian cance ......"23318422
hsa-miR-185-3p

liver cancerAFP"There was no direct relationship between miR-185 a ......"23648054
hsa-miR-185-3p

prostate cancerAGO2"Putative miRNA response element MRE of miR-185 in ......"26940039
hsa-miR-185-3p

lung squamous cell cancerAKT1"MiR 185 acts as a tumor suppressor by targeting AK ......"26617940
hsa-miR-185-3p

gastric cancerARC"In elucidating the molecular mechanism by which mi ......"24763054
hsa-miR-185-3p

prostate cancerBRD8"Putative miRNA response element MRE of miR-185 in ......"26940039
hsa-miR-185-3p

colorectal cancerCCND1"Mechanically we demonstrated that miR-185 could su ......"27453420
hsa-miR-185-3p

prostate cancerCDC6"CDC6 one target of AR and an important regulatory ......"23417242
hsa-miR-185-3p

lung squamous cell cancerCDK6"Using miRNA-target prediction analyses and the arr ......"19688090
hsa-miR-185-3p

gastric cancerFRTS1"Moreover miR-185 might independently predict OS an ......"24352663
hsa-miR-185-3p

breast cancerHMGA2"RKIP suppresses the proliferation and metastasis o ......"27651238
hsa-miR-185-3p

breast cancerMET"MicroRNA 185 inhibits proliferation by targeting c ......"25371748
hsa-miR-185-3p

colorectal cancerMYC"Mechanically we demonstrated that miR-185 could su ......"27453420
hsa-miR-185-3p

liver cancerNTSR1"We classified 95 patients with early stage HCC int ......"23648054
hsa-miR-185-3p

breast cancerPEBP1"RKIP suppresses the proliferation and metastasis o ......"27651238
hsa-miR-185-3p

liver cancerPTEN"These results provide novel evidence that miR-185 ......"24911372
hsa-miR-185-3p

esophageal cancerRTCA"The xCELLigence RTCA MP system and Transwell assay ......"24025511
hsa-miR-185-3p

gastric cancerRUNX3"Finally we found that RUNX3 Runt-related transcrip ......"24763054
hsa-miR-185-3p

esophageal cancerSIX1"After transfection of miR-185 inhibitor into KYSE3 ......"24025511
hsa-miR-185-3p

liver cancerSIX2"MicroRNA 185 inhibits cell proliferation and epith ......"27212161
hsa-miR-185-3p

colorectal cancerSTIM1"STIM1 a direct target of microRNA 185 promotes tum ......"25531324
hsa-miR-185-3p

gastric cancerTRIM29"TRIM29 functions as an oncogene in gastric cancer ......"26191199
hsa-miR-185-3p

kidney renal cell cancerVEGFA"MicroRNA 185 inhibits cell proliferation and induc ......"25700976
hsa-miR-185-3p

kidney renal cell cancerVHL"We used 786O A498 VHL inactivated and Caki-1 VHL i ......"25700976
hsa-miR-185-3p

liver cancerVIM"We also found that ectopic expression of miR-185 r ......"27212161


Expression profile in cancer corhorts:



Putative target regulations

miRNAGeneCancerInteractionCorrelation beta
hsa-miR-185-3p
LRRC32
9 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LIHC; THCA; UCEC
MirTarget
TCGA BLCA -0.363; TCGA BRCA -0.202; TCGA CESC -0.273; TCGA COAD -0.305; TCGA ESCA -0.34; TCGA KIRC -0.143; TCGA LIHC -0.119; TCGA THCA -0.16; TCGA UCEC -0.258
hsa-miR-185-3p
TCF7L1
9 cancers: BLCA; COAD; KIRC; KIRP; LGG; OV; SARC; THCA; STAD
MirTarget
TCGA BLCA -0.265; TCGA COAD -0.297; TCGA KIRC -0.173; TCGA KIRP -0.186; TCGA LGG -0.148; TCGA OV -0.183; TCGA SARC -0.16; TCGA THCA -0.149; TCGA STAD -0.402
hsa-miR-185-3p
ATP1B2
11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; OV; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.268; TCGA BRCA -0.317; TCGA CESC -0.282; TCGA COAD -0.493; TCGA ESCA -0.522; TCGA KIRC -0.387; TCGA KIRP -0.188; TCGA OV -0.25; TCGA THCA -0.335; TCGA STAD -0.673; TCGA UCEC -0.539
hsa-miR-185-3p
PRELP
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; OV; SARC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.828; TCGA BRCA -0.276; TCGA CESC -0.512; TCGA COAD -0.756; TCGA ESCA -0.956; TCGA KIRC -0.297; TCGA LUAD -0.159; TCGA LUSC -0.224; TCGA OV -0.247; TCGA SARC -0.958; TCGA THCA -0.366; TCGA STAD -0.911; TCGA UCEC -0.739
hsa-miR-185-3p
CORO2B
11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; OV; STAD; UCEC
MirTarget
TCGA BLCA -0.269; TCGA BRCA -0.337; TCGA CESC -0.257; TCGA COAD -0.409; TCGA ESCA -0.472; TCGA KIRC -0.39; TCGA KIRP -0.216; TCGA LUAD -0.224; TCGA OV -0.284; TCGA STAD -0.477; TCGA UCEC -0.504
hsa-miR-185-3p
HSPA12A
9 cancers: BLCA; BRCA; CESC; ESCA; KIRC; KIRP; LUAD; STAD; UCEC
MirTarget
TCGA BLCA -0.334; TCGA BRCA -0.117; TCGA CESC -0.168; TCGA ESCA -0.25; TCGA KIRC -0.179; TCGA KIRP -0.337; TCGA LUAD -0.174; TCGA STAD -0.381; TCGA UCEC -0.115
hsa-miR-185-3p
FAM131B
9 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.276; TCGA BRCA -0.153; TCGA CESC -0.207; TCGA COAD -0.275; TCGA KIRC -0.111; TCGA KIRP -0.17; TCGA THCA -0.251; TCGA STAD -0.288; TCGA UCEC -0.431
hsa-miR-185-3p
FMOD
10 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUSC; OV; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.491; TCGA BRCA -0.376; TCGA CESC -0.258; TCGA COAD -0.269; TCGA ESCA -0.377; TCGA LUSC -0.179; TCGA OV -0.285; TCGA SARC -0.639; TCGA STAD -0.254; TCGA UCEC -0.438
hsa-miR-185-3p
MFGE8
10 cancers: BLCA; CESC; COAD; ESCA; LUAD; LUSC; SARC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.269; TCGA CESC -0.119; TCGA COAD -0.282; TCGA ESCA -0.191; TCGA LUAD -0.097; TCGA LUSC -0.115; TCGA SARC -0.292; TCGA THCA -0.277; TCGA STAD -0.128; TCGA UCEC -0.113
hsa-miR-185-3p
ZCCHC24
11 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LUAD; LUSC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.451; TCGA BRCA -0.326; TCGA CESC -0.223; TCGA COAD -0.293; TCGA ESCA -0.507; TCGA LGG -0.079; TCGA LUAD -0.089; TCGA LUSC -0.141; TCGA THCA -0.081; TCGA STAD -0.585; TCGA UCEC -0.406
hsa-miR-185-3p
ZBTB4
11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.117; TCGA BRCA -0.178; TCGA CESC -0.086; TCGA COAD -0.122; TCGA ESCA -0.217; TCGA KIRC -0.12; TCGA KIRP -0.066; TCGA LUAD -0.077; TCGA SARC -0.116; TCGA STAD -0.339; TCGA UCEC -0.17
hsa-miR-185-3p
CTDSP2
10 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; OV; STAD; UCEC
MirTarget
TCGA BLCA -0.122; TCGA BRCA -0.098; TCGA CESC -0.074; TCGA COAD -0.059; TCGA ESCA -0.07; TCGA KIRC -0.07; TCGA KIRP -0.076; TCGA OV -0.078; TCGA STAD -0.094; TCGA UCEC -0.056
hsa-miR-185-3p
NFATC4
11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUAD; SARC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.271; TCGA BRCA -0.221; TCGA COAD -0.162; TCGA ESCA -0.315; TCGA HNSC -0.109; TCGA KIRP -0.311; TCGA LUAD -0.155; TCGA SARC -0.18; TCGA THCA -0.109; TCGA STAD -0.437; TCGA UCEC -0.213
hsa-miR-185-3p
PALM
10 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LUAD; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.414; TCGA BRCA -0.36; TCGA COAD -0.379; TCGA ESCA -0.393; TCGA KIRC -0.361; TCGA KIRP -0.263; TCGA LUAD -0.131; TCGA THCA -0.331; TCGA STAD -0.452; TCGA UCEC -0.229
hsa-miR-185-3p
RHBDL3
9 cancers: BLCA; BRCA; COAD; ESCA; LGG; LUAD; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.203; TCGA BRCA -0.309; TCGA COAD -0.318; TCGA ESCA -0.301; TCGA LGG -0.119; TCGA LUAD -0.207; TCGA SARC -0.408; TCGA STAD -0.36; TCGA UCEC -0.184
hsa-miR-185-3p
PHYHIPL
10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; LIHC; SARC; STAD
MirTarget
TCGA BLCA -0.389; TCGA BRCA -0.387; TCGA COAD -0.563; TCGA ESCA -0.53; TCGA HNSC -0.263; TCGA KIRC -0.219; TCGA LGG -0.113; TCGA LIHC -0.252; TCGA SARC -0.556; TCGA STAD -0.494
hsa-miR-185-3p
RGMA
13 cancers: BLCA; CESC; COAD; ESCA; KIRC; KIRP; LIHC; OV; PAAD; SARC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.573; TCGA CESC -0.29; TCGA COAD -0.74; TCGA ESCA -0.412; TCGA KIRC -0.242; TCGA KIRP -0.224; TCGA LIHC -0.179; TCGA OV -0.149; TCGA PAAD -0.355; TCGA SARC -0.183; TCGA THCA -0.241; TCGA STAD -1.054; TCGA UCEC -0.398
hsa-miR-185-3p
CNN1
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; SARC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -1.146; TCGA BRCA -0.557; TCGA CESC -0.462; TCGA COAD -0.818; TCGA ESCA -1.091; TCGA KIRC -0.22; TCGA LIHC -0.259; TCGA LUAD -0.192; TCGA LUSC -0.261; TCGA SARC -1.444; TCGA THCA -0.334; TCGA STAD -1.454; TCGA UCEC -0.837
hsa-miR-185-3p
HSPA12B
10 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LIHC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.318; TCGA BRCA -0.306; TCGA CESC -0.178; TCGA COAD -0.179; TCGA ESCA -0.244; TCGA KIRC -0.204; TCGA LIHC -0.156; TCGA THCA -0.108; TCGA STAD -0.149; TCGA UCEC -0.358
hsa-miR-185-3p
ILK
9 cancers: BLCA; COAD; ESCA; HNSC; LUSC; PAAD; SARC; STAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.248; TCGA COAD -0.152; TCGA ESCA -0.12; TCGA HNSC -0.074; TCGA LUSC -0.086; TCGA PAAD -0.08; TCGA SARC -0.256; TCGA STAD -0.375; TCGA UCEC -0.128
hsa-miR-185-3p
ARHGEF17
10 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUAD; SARC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.201; TCGA BRCA -0.149; TCGA CESC -0.116; TCGA COAD -0.207; TCGA ESCA -0.276; TCGA LUAD -0.108; TCGA SARC -0.314; TCGA THCA -0.108; TCGA STAD -0.269; TCGA UCEC -0.158
hsa-miR-185-3p
SSPN
10 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUSC; SARC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.311; TCGA BRCA -0.236; TCGA CESC -0.157; TCGA COAD -0.45; TCGA ESCA -0.488; TCGA LUSC -0.28; TCGA SARC -0.234; TCGA THCA -0.162; TCGA STAD -0.565; TCGA UCEC -0.371
hsa-miR-185-3p
CTF1
10 cancers: BLCA; BRCA; COAD; KIRC; KIRP; PAAD; SARC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.189; TCGA BRCA -0.3; TCGA COAD -0.324; TCGA KIRC -0.265; TCGA KIRP -0.262; TCGA PAAD -0.194; TCGA SARC -0.455; TCGA THCA -0.245; TCGA STAD -0.529; TCGA UCEC -0.279
hsa-miR-185-3p
NFIX
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LUAD; OV; PAAD; SARC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.348; TCGA BRCA -0.134; TCGA CESC -0.19; TCGA COAD -0.075; TCGA ESCA -0.2; TCGA LGG -0.073; TCGA LUAD -0.177; TCGA OV -0.102; TCGA PAAD -0.115; TCGA SARC -0.182; TCGA THCA -0.088; TCGA STAD -0.344; TCGA UCEC -0.278
hsa-miR-185-3p
SLC27A1
10 cancers: BLCA; BRCA; HNSC; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.177; TCGA BRCA -0.242; TCGA HNSC -0.108; TCGA LUAD -0.206; TCGA LUSC -0.101; TCGA OV -0.114; TCGA PAAD -0.309; TCGA THCA -0.126; TCGA STAD -0.082; TCGA UCEC -0.135
hsa-miR-185-3p
ZBTB47
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.203; TCGA BRCA -0.147; TCGA CESC -0.144; TCGA COAD -0.123; TCGA ESCA -0.29; TCGA HNSC -0.155; TCGA LGG -0.06; TCGA LUAD -0.093; TCGA LUSC -0.094; TCGA PAAD -0.118; TCGA SARC -0.231; TCGA STAD -0.351; TCGA UCEC -0.145
hsa-miR-185-3p
MAPK4
9 cancers: BLCA; COAD; ESCA; KIRC; KIRP; OV; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.476; TCGA COAD -0.904; TCGA ESCA -1.094; TCGA KIRC -0.819; TCGA KIRP -0.329; TCGA OV -0.359; TCGA SARC -1.437; TCGA STAD -1.438; TCGA UCEC -0.374
hsa-miR-185-3p
CCL14
11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.922; TCGA BRCA -0.683; TCGA CESC -0.701; TCGA COAD -0.722; TCGA ESCA -0.956; TCGA HNSC -0.341; TCGA KIRC -0.165; TCGA LUAD -0.183; TCGA SARC -0.367; TCGA STAD -0.879; TCGA UCEC -0.817
hsa-miR-185-3p
KY
11 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUAD; LUSC; OV; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.666; TCGA BRCA -0.515; TCGA CESC -0.357; TCGA COAD -0.295; TCGA ESCA -0.572; TCGA LUAD -0.23; TCGA LUSC -0.355; TCGA OV -0.269; TCGA SARC -0.766; TCGA STAD -0.956; TCGA UCEC -0.512
hsa-miR-185-3p
MTMR10
10 cancers: BLCA; BRCA; CESC; ESCA; KIRC; KIRP; LIHC; LUAD; STAD; UCEC
MirTarget
TCGA BLCA -0.095; TCGA BRCA -0.126; TCGA CESC -0.1; TCGA ESCA -0.078; TCGA KIRC -0.162; TCGA KIRP -0.136; TCGA LIHC -0.072; TCGA LUAD -0.061; TCGA STAD -0.184; TCGA UCEC -0.062
hsa-miR-185-3p
SLC9A3R2
10 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; THCA
mirMAP
TCGA BLCA -0.09; TCGA BRCA -0.128; TCGA HNSC -0.123; TCGA KIRC -0.236; TCGA KIRP -0.205; TCGA LIHC -0.125; TCGA LUAD -0.099; TCGA LUSC -0.108; TCGA PAAD -0.266; TCGA THCA -0.133
hsa-miR-185-3p
TNS1
9 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; SARC; STAD; UCEC
mirMAP
TCGA BLCA -0.671; TCGA BRCA -0.279; TCGA CESC -0.192; TCGA COAD -0.487; TCGA ESCA -0.723; TCGA KIRC -0.102; TCGA SARC -0.516; TCGA STAD -0.782; TCGA UCEC -0.415
hsa-miR-185-3p
CRTC1
11 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; LUAD; OV; PAAD; THCA; STAD; UCEC
mirMAP
TCGA BLCA -0.101; TCGA BRCA -0.113; TCGA ESCA -0.145; TCGA KIRC -0.114; TCGA KIRP -0.181; TCGA LUAD -0.156; TCGA OV -0.095; TCGA PAAD -0.148; TCGA THCA -0.168; TCGA STAD -0.145; TCGA UCEC -0.059
hsa-miR-185-3p
VIPR2
15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; OV; PAAD; SARC; STAD; UCEC
mirMAP
TCGA BLCA -0.736; TCGA BRCA -0.613; TCGA CESC -0.458; TCGA COAD -0.628; TCGA ESCA -1.052; TCGA HNSC -0.214; TCGA KIRC -0.255; TCGA KIRP -0.204; TCGA LGG -0.307; TCGA LUSC -0.288; TCGA OV -0.277; TCGA PAAD -0.485; TCGA SARC -1.02; TCGA STAD -1.079; TCGA UCEC -0.602
hsa-miR-185-3p
TSPAN11
10 cancers: BLCA; BRCA; COAD; ESCA; LGG; LUAD; LUSC; THCA; STAD; UCEC
mirMAP
TCGA BLCA -0.283; TCGA BRCA -0.182; TCGA COAD -0.335; TCGA ESCA -0.448; TCGA LGG -0.141; TCGA LUAD -0.398; TCGA LUSC -0.227; TCGA THCA -0.266; TCGA STAD -0.371; TCGA UCEC -0.267
hsa-miR-185-3p
LDB3
13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; OV; SARC; THCA; STAD; UCEC
mirMAP
TCGA BLCA -0.488; TCGA BRCA -0.203; TCGA COAD -0.801; TCGA ESCA -0.955; TCGA HNSC -0.38; TCGA KIRC -0.265; TCGA LIHC -0.199; TCGA LUAD -0.198; TCGA OV -0.126; TCGA SARC -0.97; TCGA THCA -0.2; TCGA STAD -1.38; TCGA UCEC -0.418
hsa-miR-185-3p
MXD4
12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; OV; THCA; STAD; UCEC
mirMAP
TCGA BLCA -0.106; TCGA BRCA -0.139; TCGA CESC -0.085; TCGA ESCA -0.127; TCGA HNSC -0.116; TCGA LGG -0.066; TCGA LUAD -0.102; TCGA LUSC -0.104; TCGA OV -0.121; TCGA THCA -0.104; TCGA STAD -0.131; TCGA UCEC -0.103
hsa-miR-185-3p
THRA
10 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LGG; OV; SARC; STAD; UCEC
mirMAP
TCGA BLCA -0.247; TCGA BRCA -0.125; TCGA CESC -0.089; TCGA KIRC -0.221; TCGA KIRP -0.142; TCGA LGG -0.069; TCGA OV -0.119; TCGA SARC -0.225; TCGA STAD -0.092; TCGA UCEC -0.225
hsa-miR-185-3p
PER2
9 cancers: BLCA; BRCA; ESCA; KIRP; LIHC; SARC; THCA; STAD; UCEC
mirMAP
TCGA BLCA -0.181; TCGA BRCA -0.25; TCGA ESCA -0.167; TCGA KIRP -0.128; TCGA LIHC -0.076; TCGA SARC -0.218; TCGA THCA -0.074; TCGA STAD -0.099; TCGA UCEC -0.15
hsa-miR-185-3p
SCN2B
14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; SARC; THCA; STAD; UCEC
mirMAP
TCGA BLCA -0.713; TCGA BRCA -0.918; TCGA CESC -0.499; TCGA COAD -0.79; TCGA ESCA -0.853; TCGA HNSC -0.281; TCGA KIRC -0.721; TCGA LUAD -0.176; TCGA LUSC -0.379; TCGA OV -0.3; TCGA SARC -0.782; TCGA THCA -0.37; TCGA STAD -1.077; TCGA UCEC -0.51
hsa-miR-185-3p
KCTD15
10 cancers: BLCA; CESC; COAD; KIRC; KIRP; LGG; LUAD; SARC; STAD; UCEC
mirMAP
TCGA BLCA -0.277; TCGA CESC -0.196; TCGA COAD -0.276; TCGA KIRC -0.158; TCGA KIRP -0.22; TCGA LGG -0.068; TCGA LUAD -0.139; TCGA SARC -0.359; TCGA STAD -0.314; TCGA UCEC -0.195
hsa-miR-185-3p
PLIN4
12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; PAAD; SARC; THCA; STAD; UCEC
mirMAP
TCGA BLCA -0.339; TCGA BRCA -0.61; TCGA CESC -0.345; TCGA COAD -0.759; TCGA ESCA -0.825; TCGA HNSC -0.34; TCGA LUAD -0.37; TCGA PAAD -0.648; TCGA SARC -1.163; TCGA THCA -0.203; TCGA STAD -1.39; TCGA UCEC -0.461
hsa-miR-185-3p
PRIMA1
9 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LUAD; SARC; STAD; UCEC
mirMAP
TCGA BLCA -0.621; TCGA BRCA -0.16; TCGA COAD -1.147; TCGA ESCA -0.751; TCGA KIRP -0.419; TCGA LUAD -0.233; TCGA SARC -0.903; TCGA STAD -1.558; TCGA UCEC -0.202
hsa-miR-185-3p
GNG7
14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; SARC; STAD; UCEC
mirMAP
TCGA BLCA -0.439; TCGA BRCA -0.278; TCGA CESC -0.223; TCGA COAD -0.34; TCGA ESCA -0.667; TCGA HNSC -0.206; TCGA KIRC -0.23; TCGA KIRP -0.151; TCGA LIHC -0.236; TCGA LUAD -0.293; TCGA LUSC -0.216; TCGA SARC -0.344; TCGA STAD -0.664; TCGA UCEC -0.402
hsa-miR-185-3p
SCN4B
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; OV; SARC; THCA; STAD; UCEC
mirMAP
TCGA BLCA -0.276; TCGA BRCA -0.53; TCGA CESC -0.359; TCGA COAD -0.468; TCGA ESCA -0.569; TCGA LIHC -0.171; TCGA LUAD -0.24; TCGA LUSC -0.214; TCGA OV -0.224; TCGA SARC -0.415; TCGA THCA -0.166; TCGA STAD -0.666; TCGA UCEC -0.531
hsa-miR-185-3p
LDLRAD2
12 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC
mirMAP
TCGA BLCA -0.238; TCGA BRCA -0.117; TCGA ESCA -0.115; TCGA HNSC -0.137; TCGA KIRP -0.154; TCGA LUAD -0.094; TCGA LUSC -0.08; TCGA PAAD -0.246; TCGA SARC -0.198; TCGA THCA -0.212; TCGA STAD -0.146; TCGA UCEC -0.103
hsa-miR-185-3p
PRX
12 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; LIHC; LUAD; PAAD; SARC; THCA; STAD; UCEC
miRNATAP
TCGA BLCA -0.203; TCGA BRCA -0.302; TCGA ESCA -0.221; TCGA KIRC -0.238; TCGA KIRP -0.142; TCGA LIHC -0.102; TCGA LUAD -0.127; TCGA PAAD -0.159; TCGA SARC -0.108; TCGA THCA -0.095; TCGA STAD -0.263; TCGA UCEC -0.235
hsa-miR-185-3p
NPTX1
11 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LUAD; LUSC; SARC; THCA; STAD; UCEC
miRNATAP
TCGA BLCA -0.414; TCGA BRCA -0.227; TCGA COAD -0.877; TCGA ESCA -0.625; TCGA KIRC -0.222; TCGA LUAD -0.27; TCGA LUSC -0.22; TCGA SARC -0.721; TCGA THCA -0.323; TCGA STAD -1.207; TCGA UCEC -0.358
hsa-miR-185-3p
RUNX1T1
9 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; SARC; STAD; UCEC
miRNATAP
TCGA BLCA -0.552; TCGA BRCA -0.351; TCGA CESC -0.26; TCGA COAD -0.578; TCGA ESCA -0.666; TCGA KIRC -0.323; TCGA SARC -0.164; TCGA STAD -0.589; TCGA UCEC -0.617
hsa-miR-185-3p
VAMP2
13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; SARC; STAD; UCEC
miRNATAP
TCGA BLCA -0.122; TCGA BRCA -0.192; TCGA CESC -0.08; TCGA ESCA -0.217; TCGA HNSC -0.161; TCGA KIRC -0.18; TCGA KIRP -0.15; TCGA LUAD -0.109; TCGA LUSC -0.078; TCGA OV -0.088; TCGA SARC -0.148; TCGA STAD -0.316; TCGA UCEC -0.212
hsa-miR-185-3p
DCHS1
9 cancers: BLCA; BRCA; CESC; COAD; ESCA; SARC; THCA; STAD; UCEC
miRNATAP
TCGA BLCA -0.339; TCGA BRCA -0.136; TCGA CESC -0.161; TCGA COAD -0.152; TCGA ESCA -0.349; TCGA SARC -0.193; TCGA THCA -0.15; TCGA STAD -0.268; TCGA UCEC -0.286
hsa-miR-185-3p
APBB1
10 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; OV; SARC; STAD; UCEC
miRNATAP
TCGA BLCA -0.36; TCGA BRCA -0.168; TCGA CESC -0.18; TCGA COAD -0.338; TCGA ESCA -0.424; TCGA KIRC -0.083; TCGA OV -0.185; TCGA SARC -0.225; TCGA STAD -0.487; TCGA UCEC -0.269
hsa-miR-185-3p
EPN2
10 cancers: BRCA; CESC; KIRC; KIRP; LUAD; OV; SARC; THCA; STAD; UCEC
MirTarget
TCGA BRCA -0.065; TCGA CESC -0.145; TCGA KIRC -0.074; TCGA KIRP -0.15; TCGA LUAD -0.059; TCGA OV -0.074; TCGA SARC -0.217; TCGA THCA -0.054; TCGA STAD -0.189; TCGA UCEC -0.099
hsa-miR-185-3p
ZNF862
13 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; SARC; THCA; STAD; UCEC
MirTarget
TCGA BRCA -0.145; TCGA CESC -0.148; TCGA ESCA -0.235; TCGA HNSC -0.137; TCGA KIRP -0.211; TCGA LGG -0.071; TCGA LIHC -0.099; TCGA LUAD -0.163; TCGA LUSC -0.14; TCGA SARC -0.123; TCGA THCA -0.064; TCGA STAD -0.162; TCGA UCEC -0.171
hsa-miR-185-3p
MLLT6
10 cancers: BRCA; CESC; ESCA; KIRC; KIRP; LUAD; PAAD; SARC; THCA; UCEC
MirTarget; mirMAP
TCGA BRCA -0.068; TCGA CESC -0.088; TCGA ESCA -0.093; TCGA KIRC -0.095; TCGA KIRP -0.184; TCGA LUAD -0.103; TCGA PAAD -0.128; TCGA SARC -0.177; TCGA THCA -0.092; TCGA UCEC -0.063
hsa-miR-185-3p
SH2B1
13 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; SARC; THCA; UCEC
MirTarget; miRNATAP
TCGA BRCA -0.104; TCGA CESC -0.106; TCGA ESCA -0.073; TCGA HNSC -0.122; TCGA KIRP -0.146; TCGA LGG -0.061; TCGA LUAD -0.181; TCGA LUSC -0.148; TCGA OV -0.131; TCGA PAAD -0.127; TCGA SARC -0.151; TCGA THCA -0.08; TCGA UCEC -0.053
hsa-miR-185-3p
CROCC
9 cancers: BRCA; CESC; KIRP; LGG; LUAD; OV; PAAD; THCA; UCEC
MirTarget
TCGA BRCA -0.121; TCGA CESC -0.179; TCGA KIRP -0.097; TCGA LGG -0.056; TCGA LUAD -0.202; TCGA OV -0.106; TCGA PAAD -0.289; TCGA THCA -0.136; TCGA UCEC -0.123
hsa-miR-185-3p
OSBPL7
9 cancers: BRCA; KIRP; LGG; LUAD; LUSC; PAAD; SARC; THCA; UCEC
mirMAP
TCGA BRCA -0.149; TCGA KIRP -0.137; TCGA LGG -0.084; TCGA LUAD -0.268; TCGA LUSC -0.182; TCGA PAAD -0.325; TCGA SARC -0.075; TCGA THCA -0.099; TCGA UCEC -0.095
hsa-miR-185-3p
SGSM2
12 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; SARC; THCA; STAD; UCEC
mirMAP
TCGA BRCA -0.175; TCGA CESC -0.106; TCGA ESCA -0.162; TCGA HNSC -0.203; TCGA KIRP -0.133; TCGA LIHC -0.11; TCGA LUAD -0.206; TCGA LUSC -0.109; TCGA SARC -0.089; TCGA THCA -0.131; TCGA STAD -0.207; TCGA UCEC -0.055
hsa-miR-185-3p
ING5
10 cancers: BRCA; HNSC; KIRC; KIRP; LGG; LUAD; OV; PAAD; SARC; THCA
mirMAP
TCGA BRCA -0.103; TCGA HNSC -0.078; TCGA KIRC -0.091; TCGA KIRP -0.189; TCGA LGG -0.116; TCGA LUAD -0.122; TCGA OV -0.16; TCGA PAAD -0.091; TCGA SARC -0.142; TCGA THCA -0.066
hsa-miR-185-3p
SLC25A42
10 cancers: BRCA; CESC; COAD; ESCA; LIHC; LUAD; OV; SARC; STAD; UCEC
mirMAP
TCGA BRCA -0.09; TCGA CESC -0.113; TCGA COAD -0.105; TCGA ESCA -0.219; TCGA LIHC -0.148; TCGA LUAD -0.126; TCGA OV -0.106; TCGA SARC -0.097; TCGA STAD -0.244; TCGA UCEC -0.13
hsa-miR-185-3p
FLRT1
10 cancers: CESC; ESCA; KIRC; KIRP; LGG; LUAD; OV; PAAD; STAD; UCEC
MirTarget
TCGA CESC -0.169; TCGA ESCA -0.218; TCGA KIRC -0.595; TCGA KIRP -0.437; TCGA LGG -0.092; TCGA LUAD -0.215; TCGA OV -0.255; TCGA PAAD -0.219; TCGA STAD -0.613; TCGA UCEC -0.265
hsa-miR-185-3p
MAP2K7
11 cancers: CESC; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD
mirMAP
TCGA CESC -0.064; TCGA HNSC -0.056; TCGA KIRP -0.053; TCGA LIHC -0.074; TCGA LUAD -0.063; TCGA LUSC -0.056; TCGA OV -0.069; TCGA PAAD -0.147; TCGA SARC -0.086; TCGA THCA -0.082; TCGA STAD -0.057




Enriched cancer pathways of putative targets